Home/Pipeline/Ocuphire Pharma Collaboration

Ocuphire Pharma Collaboration

Not Specified (Ophthalmic)

Not SpecifiedActive

Key Facts

Indication
Not Specified (Ophthalmic)
Phase
Not Specified
Status
Active
Company

About Voxeleron

Voxeleron is a technology and services company that leverages artificial intelligence and machine learning to analyze ophthalmic images for clinical research. Its core platform, iNebula, facilitates the management, analysis, and sharing of complex imaging datasets, aiming to accelerate ophthalmic drug development by providing standardized, device-agnostic insights. Recently acquired by Voiant, Voxeleron operates as a strategic component within a larger clinical trial imaging ecosystem, serving pharmaceutical sponsors and research organizations. The company is ISO 13485:2016 certified, indicating a quality management system for medical devices.

View full company profile

Therapeutic Areas